S'abonner

Intercenter variability in outcome for patients treated with direct coronary angioplasty during acute myocardial infarction - 09/09/11

Doi : 10.1016/S0002-8703(98)70098-5 
Timothy F. Christian, MD, FACCa, James H. O'Keefe, MD, FACCb, Marcus A. DeWood, MD, FACCc, Michael G. Spain, MD, FACCd, Cindy L. Grines, MD, FACCb, Peter B. Berger, MD, FACCa, Raymond J. Gibbons, MD, FACCa
Rochester, Minn.; Kansas City, Mo.; Royal Oak, Mich.; Spokane, Wash.; and Tulsa, Okla 

Abstract

Background Direct coronary angioplasty is an effective therapy for acute myocardial infarction, but its success may be dependent on both ready availability and operator skill. The purpose of this study was to investigate the impact of the center performing direct coronary angioplasty for acute myocardial infarction while controlling for parameters known to affect outcome. Methods and Results The study group consisted of 99 patients with ST elevation who were treated with direct angioplasty in four high-volume centers. Patients were injected with technetium-99m sestamibi intravenously and then taken to the cardiac catheterization laboratory. Antegrade flow was graded before and after direct coronary angioplasty. Single photon emission computed tomography was performed 1 to 6 hours after injection to measure myocardium at risk and residual blood flow to the jeopardized zone using previously published quantitative methods. A repeat sestamibi injection and tomographic acquisition were performed at hospital discharge to measure actual infarct size. There were no significant differences by center for baseline clinical characteristics, mean myocardium at risk (29% to 37% left ventricle [LV]), time to reperfusion (3.1 to 4.1 hours), residual blood flow, infarct location, or antegrade flow. Despite these similarities, there were differences in outcome measures by center. Mean infarct size was as follows: center 1, 15%; center 2, 12%; center 3, 10%, center 4, 23% (all LV; p = 0.11). Mean left ventricular ejection fraction at discharge also demonstrated significant differences: center 1, 0.57; center 2, 0.47; center 3, 0.53; center 4, 0.47 (p = 0.002). The prevalence of Thrombolysis in Myocardial Infarction grade 3 flow after angioplasty significantly differed by center: center 1, 92%; center 2, 94%; center 3, 87%; center 4, 71%; (p = 0.01). There was a low mortality rate for all four centers ranging from 0% to 6%. After adjustment for myocardium at risk, residual blood flow, and time to reperfusion, the primary outcome of the center where the angioplasty was performed was an independent determinant of both infarct size and left ventricular ejection fraction. Conclusion The success of direct coronary angioplasty in reducing infarct size and preserving left ventricular function depends on the center performing the procedure. Direct measurement of the effectiveness of this reperfusion modality in community practice is required to assess the impact of this effect. (Am Heart J 1998;135:310-17.)

Le texte complet de cet article est disponible en PDF.

Plan


 From the aDivision of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation; the bDepartment of Cardiovascular Diseases, St. Luke's Hospital, The Mid America Heart Institute, and the Department of Cardiovascular Diseases, William Beaumont Hospital; the c Department of Cardiovascular Diseases, Deaconess Medical Center, Spokane Heart Research Foundation; and the dDepartment of Cardiovascular Diseases, St. Francis Hospital, Tulsa Cardiology.
 Supported by a grant from Burroughs Wellcome Co., Research Triangle Park, N.C.
 Reprint requests: Timothy F. Christian, MD, Mayo Clinic, 200 First St. SW, West 16B, Rochester, MN 55905. E-mail: christian.timothy@mayo.edu
 4/1/87274


© 1998  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 135 - N° 2

P. 310-317 - février 1998 Retour au numéro
Article précédent Article précédent
  • Risk factors for acute and subacute stent thrombosis after high-pressure stent implantation: A study by intracoronary ultrasound
  • Gerald S. Werner, Oliver Gastmann, Markus Ferrari, Seda Schuenemann, Alexandra Knies, Juergen Diedrich, Heinrich Kreuzer
| Article suivant Article suivant
  • Primary coronary stenting after successful balloon angioplasty of chronic total occlusions: A single-center experience
  • Maarten J. Suttorp, E.Gijs Mast, H.W.Thijs Plokker, Johannes C. Kelder, Sjef M.P.G. Ernst, Egbert T. Bal

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.